Table 3.
Demographics of subjects for hypertension development
| Uric acid groups (mg/dL) | ||||||
|---|---|---|---|---|---|---|
| Overall | <5.0 | 5.0–5.9 | 6.0–6.9 | ≧7.0 | p | |
| N | 7569 | 2531 | 2247 | 1894 | 897 | |
| Age (years) | 39 ± 10 | 37 ± 9 | 39 ± 10 | 40 ± 9 | 41 ± 9 | <0.001 |
| Men (%) | 76.3 | 40.9 | 89.2 | 97.8 | 98.8 | <0.001 |
| BMI (Kg/m2) | 22 ± 3 | 21 ± 3 | 22 ± 3 | 23 ± 3 | 24 ± 3 | <0.001 |
| Waist circumference (cm) | 78.1 ± 8.6 | 73.9 ± 8.1 | 78.3 ± 7.8 | 80.8 ± 7.8 | 83.7 ± 8.1 | <0.001 |
| SBP (mmHg) | 115 ± 11 | 112 ± 11 | 116 ± 11 | 117 ± 10 | 119 ± 10 | <0.001 |
| DBP (mmHg) | 72 ± 8 | 70 ± 8 | 73 ± 8 | 74 ± 8 | 75 ± 7 | <0.001 |
| Cr (mg/dL) | 0.75 ± 0.14 | 0.65 ± 0.13 | 0.77 ± 0.11 | 0.80 ± 0.11 | 0.83 ± 0.11 | <0.001 |
| eGFR (mL/min/1.73 m2) | 91.4 ± 17.7 | 96.5 ± 19.6 | 91.2 ± 16.7 | 88.1 ± 15.3 | 84.1 ± 15.0 | <0.001 |
| TC (mg/dL) | 191 ± 29 | 187 ± 28 | 191 ± 29 | 194 ± 28 | 201 ± 29 | <0.001 |
| TG (mg/dL) | 91 ± 57 | 71 ± 41 | 91 ± 51 | 104 ± 62 | 125 ± 76 | <0.001 |
| HDLC (mg/dL) | 64 ± 15 | 69 ± 15 | 63 ± 15 | 61 ± 14 | 59 ± 15 | <0.001 |
| LDLC (mg/dL) | 112 ± 26 | 106 ± 25 | 113 ± 26 | 116 ± 26 | 122 ± 27 | <0.001 |
| PG (mg/dL) | 93 ± 9 | 91 ± 9 | 93 ± 10 | 94 ± 9 | 96 ± 10 | <0.001 |
| HbA1c (NGSP) (%) | 5.23 ± 0.34 | 5.20 ± 0.33 | 5.23 ± 0.32 | 5.25 ± 0.34 | 5.29 ± 0.37 | <0.001 |
UA serum uric acid concentration, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, Cr serum creatinine concentration, eGFR estimated glomerular filtration rate, TC total cholesterol, TG triglycerides, HDLC high-density lipoprotein cholesterol, LDLC low-density lipoprotein cholesterol, PG plasma glucose concentration, HbA1c glycated hemoglobin